Promising treatment for disease that destroys eye tissue

By Jan Jarvis

Eye Web

Ocular inflammation uveitis is a serious disease that can destroy eye tissue and cause irreversible blindness.

Fortunately, blindness and eye damage can be prevented by suppressing the immune system and treating the disease with corticosteroids, said Sai Chavala, MD, Professor of Pharmacology and Neuroscience and Director of Translational Research at the North Texas Eye Research Institute at UNT Health Science Center.

“While corticosteroids are effective in treating inflammation and preventing blindness, they often become intolerable over time,” he said. “There’s a risk of systemic side effects such as glucose intolerance, hypertension and osteoporosis with oral steroids.”

Treating with intraocular steroids reduces the systemic adverse effects. But this treatment can cause vision loss due to the development of a cataract or steroid-induced glaucoma.

But a class of drugs known as MDM2 inhibitors could potentially be a promising new treatment for this chronic disease, which typically strikes young and middle-aged adults. MDM2 is currently being evaluated as a cancer therapy in clinical trials.

“But we have found that the same class of drugs can inhibit ocular inflammation, which was a surprising benefit,” Dr. Chavala said.

The research team studied the effects of MDM2 in mice by using an agent that blocks MDM2. Inflammation was nearly abolished with systemic and ocular delivery of the MDM2 inhibitor.

“The results of this study are promising and suggest further research is warranted,” said Yan Fan, PhD, a post-doctoral research fellow at UNTHSC, who is first and lead author on the study.

The findings appear in the September issue of the American Journal of Pathology.

Uveitis is estimated to account for 10 percent of all cases of blindness in the United States, including 30,000 new cases of legal blindness each year. It is affects about 200,000 people in the United States. Although it usually occurs in adults, about 5 percent to 10 percent of cases start before age 16. About 43,000 new cases are diagnosed in the United States each year.

The disease is caused by inflammatory responses inside the eye, perhaps because of an attack from the body’s immune system. Infections or tumors, bruises and toxins that penetrate the eye might also lead to the disease.

Symptoms include blurred vision, eye pain and redness. Awareness of the disease has increased as celebrities such as Mila Kunis have publicly commented on the struggles uveitis patients have with vision impairment.

Co-authors for the study include Wei Zhang, Aiguo Ni and Biraj Mahato from the Department of Pharmacology and Neuroscience.

The Nancy Lee and Perry R. Bass Endowment, the Foundation Fighting Blindness and the National Eye Institutes support the study.


Disclosure statement: Dr. Chavala is founder, CEO and President of Serrata, LLC, a company that plans to commercialize MDM2 inhibitors for the treatment of ocular disease.

Recent News

Wheels For Wellness Check Presentation
  • Research
|Mar 24, 2023

Wheels for Wellness and a cure: Fort Worth nonprofit supports cancer research at HSC 

Every September, thousands of car buffs pack Downtown Fort Worth to get an up-close look at hot rods, classic cars, restomods and one-of-a-kind first-responder vehicles. For some, a trip to this car show could save their lives.  They come for the cars, but the event’s organizer, Wheels for Wel...
Kim Fulda 2 Final 1 Scaled
  • Research
|Mar 23, 2023

NorTex receives grant to improve outcomes for people with developmental disabilities and substance use disorder

The Texas Council for Developmental Disabilities has awarded the North Texas Primary Care Practice-Based Research Network at The University of North Texas Health Science Center at Fort Worth a five-year grant up to $750,000 to continue research to improve outcomes for individuals with developmenta...
Sparks Closeup
  • Our People
|Mar 16, 2023

Heading home to Midland, TCOM’s Clarence Sparks is the first from the PCPP to participate in Match Day

Samantha Hustak remembers the taunts as a little girl. Katie Walter will never forget the day she got the news her athletic career was over. At the age of 45, Rachael Haines, a wife and mother of four, was ready for medical school and Clarence Sparks, a one-time college dropout, is now ready to head...
Austin Davis And Selina Tucker Banner Copy
  • Research
|Mar 16, 2023

SBS students awarded prestigious American Heart Association fellowships  

Austin Davis and Selina Tucker, both Ph.D. candidates in The University of North Texas Health Science Center at Fort Worth’s School of Biomedical Sciences, were awarded two-year predoctoral fellowships from the American Heart Association.    AHA grants predoctoral fellowships to enhance the ...